Cefixime Impurity 4

Product Description
CAT No.
ALN-C081018
CAS No.
NA
Mol. F.
C16H15N5O7S2
Mol. Wt.
453.4
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 2-((((Z)-1-(2-Aminothiazol-4-yl)-2-(((2R,2aR)-6-hydroxy-1,7-dioxo-2,2a,4,5,6,7-hexahydro-1H-azeto[2,1-b]cyclopenta[d][1,3]thiazin-2-yl)amino)-2-oxoethylidene)amino)oxy)acetic acid
Smiles : O=C(O)CO/N=C(C1=CSC(N)=N1)\C(N[C@]([C@]2([H])N3C(C(C(O)C4)=O)=C4CS2)([H])C3=O)=O
Inchi : InChI=1S/C16H15N5O7S2/c17-16-18-7(5-30-16)9(20-28-3-8(22)23)12(24)19-10-13(25)21-11-6(4-29-14(10)21)1-2-27-15(11)26/h5,10,14H,1-4H2,(H2,17,18)(H,19,24)(H,22,23)/b20-9-/t10-,14-/m1/s1
Technical Data
Reference
Analytical method development and validation of cefixime and azithromycin by using RP-HPLC
By Sireesha, E.; Reddy, L. Ramachandra; Dhachinamoorthi, D.nFrom World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(9), 1160-1177
Stability indicating hplc method for the quantification of cefixime, ornidazole and moxifloxacin in solid dosage forms
By Palacharla, Suresh Kumar; Mohan, G. V. Krishna – From Rasayan Journal of Chemistry (2018), 11(4), 1696-1714
Validated stability-indicating HPTLC method for cefixime and azithromycin with preparative isolation, identification, and characterization of degradation products
By Gawande, V. T.; Bothara, K. G.; Satija, C. O. – From Acta Chromatographica (2018), 30(4), 212-218
RFQ